Appendectomy and Cancer Risk: New Study Finds a Surprising Link

What the study found

A new appendectomy and cancer risk study suggests that decision might matter for longer than anyone thought. Patients who had their appendix removed for acute appendicitis were later diagnosed with colorectal cancer far less often than patients who were treated with antibiotics alone, according to research presented at the American College of Surgeons Clinical Congress 2026 in Washington. The appendectomy and cancer risk connection showed up in a large retrospective analysis, and it surprised the researchers who found it. Becker's ASC reported the findings ahead of the presentation in late September.

The research team drew on the TriNetX Global Collaborative Network, a health records database spanning 168 healthcare organizations, to assemble a matched cohort of more than thirty thousand patients diagnosed with acute appendicitis. After excluding patients who already had a colorectal cancer diagnosis, the numbers diverged sharply. Cancer was later diagnosed in 0.7 percent of the fifteen thousand six hundred sixteen appendectomy patients, a total of 110 cases, compared with 1.7 percent of the fifteen thousand two hundred ninety-five patients treated with antibiotics alone, a total of 254 cases. That gap corresponds to a fifty-eight percent lower relative risk of a later colorectal cancer diagnosis in the surgery group, according to the researchers.

"The management of acute appendicitis has changed significantly over the last decade, and antibiotic therapy is now an accepted option," said Valentine Nfonsam, MD, the study's senior author and a professor and executive vice chair of the department of surgery at Morehouse School of Medicine, in the study release. Nfonsam said the team wanted to ask whether there were "long-term oncologic implications" of leaving the appendix in place after appendicitis, as Becker's ASC reported. The wording of the question hints at how much appendicitis care has shifted. Where surgery was once the automatic answer, antibiotics have become a legitimate option for select patients, and surgeons are now circling back to ask what the appendix was doing there in the first place.

What might explain the link

Nobody knows the exact mechanism yet, and the researchers are upfront about that. That is the honest state of the appendectomy and cancer risk research: striking numbers with an unknown cause. They floated three possible explanations. Surgery could simply lead to earlier detection of a hidden cancer, since the appendix is removed, examined, and surrounded by imaging and pathology work that antibiotics-only patients never get. Taking the appendix out could also remove a source of chronic inflammation, which is a known driver of cancerous changes in the colon. And then there is the appendix's newer reputation as a reserve for the gut microbiome and a player in the immune system, which would make its removal either protective or suspicious depending on which theory you prefer. The microbiome angle is worth keeping an eye on, since research on the gut's wider influence on the body keeps expanding.

Context helps here. The appendix is a small, narrow organ sitting where the small and large intestines meet, and its removal is one of the most common surgeries in the United States. When antibiotics work for appendicitis, they spare patients the operating room, and that trade-off has looked straightforward for years. The new appendectomy and cancer risk data complicates it without overturning it. Nfonsam cautioned that the findings should not push every appendicitis patient toward surgery, and said age, genetic predisposition, family history, and other colorectal cancer risk factors should still guide patient selection and follow-up, according to Becker's ASC. This is association, not causation. The results were presented as a research abstract and have not yet passed peer review, so the appendectomy and cancer risk finding is a signal worth investigating rather than a medical verdict.

For readers weighing the appendectomy and cancer risk question in practical terms, the takeaway is less dramatic than the headline number. Screening still matters more than any single treatment choice. Colorectal cancer is one of the few cancers where screening can catch the disease before it starts, and new blood tests are pushing early detection even further. If you have a family history of colorectal cancer or other risk factors, the conversation with your doctor about when to start screening matters far more than what happened to your appendix. The study does not argue that people should seek out appendix removal as prevention, and no responsible surgeon would frame it that way.

The next step is the slow work of peer review and replication, which is where a striking conference finding either becomes medical knowledge or fades into a footnote. If the appendectomy and cancer risk link holds up under that scrutiny, treatment guidelines for one of the most common surgical emergencies could eventually look different.